Distinct Occurrence of Proarrhythmic Afterdepolarizations in Atrial Versus Ventricular Cardiomyocytes: Implications

Nils Bögeholz1, Paul Pauls1,2, Dirk G Dechering1

  • 1Clinic for Cardiology II - Electrophysiology, University Hospital Münster, Münster, Germany.

Frontiers in Pharmacology
|September 7, 2018
PubMed

Insights

Murine atrial myocytes are protected against early afterdepolarizations (EADs), unlike ventricular myocytes, despite similar susceptibility to delayed afterdepolarizations (DADs). This difference in arrhythmia mechanisms is crucial for developing targeted atrial fibrillation treatments.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Translational Medicine

Background:

  • Arrhythmia mechanisms are primarily studied in ventricular cells, yet atrial arrhythmias like atrial fibrillation are more prevalent.
  • Significant differences exist between atrial and ventricular cardiomyocytes, limiting direct translation of findings.
  • Murine models are widely used but have known translational limitations for human arrhythmia research.

Purpose of the Study:

  • To directly compare atrial and ventricular cardiomyocyte mechanisms of arrhythmia in mice.
  • To identify critical differences relevant for developing antiarrhythmic strategies for atrial arrhythmias.
  • To assess the role of afterdepolarizations in murine atrial versus ventricular myocytes.

Main Methods:

  • Isolated murine atrial and ventricular myocytes were analyzed using wide-field microscopy.
  • Patch-clamp experiments were performed under a proarrhythmic protocol.
  • Delayed afterdepolarizations (DADs) and early afterdepolarizations (EADs) were evoked and quantified.

Main Results:

  • Atrial myocytes exhibited fewer spontaneous action potentials (sAPs) compared to ventricular myocytes, despite similar DAD susceptibility.
  • No EADs were observed in atrial myocytes, while they were frequent in ventricular myocytes (p < 0.05).
  • Reduced L-type Ca2+ current (ICa) and Na+/Ca2+-exchanger inward current (INCX) were found in atrial myocytes.

Conclusions:

  • Murine atrial myocytes show distinct proarrhythmic afterdepolarization profiles, being protected against EADs.
  • Reduced ICa and INCX in atrial myocytes may explain their protection against EADs.
  • Findings highlight crucial differences for murine models in developing atrial arrhythmia treatments.

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
574
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
840
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.8K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
17.9K
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.0K
Termination of Translation01:44

Termination of Translation

The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.7K